EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Generation and Immunogenicity of Virus-like Particles Based on the Capsid Protein of a Chinese Epidemic Strain of Feline Panleukopenia Virus

Erkai Feng, Guoliang Luo, Chunxia Wang, Wei Liu, Ruxun Yan, Xue Bai, Yuening Cheng

Veterinary Sciences · 20.05.2025 · 12 (5) · 503

DOI: 10.3390/vetsci12050503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 20.05.2025. Verfasst von Erkai Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Economic Animal Diseases, Ministry of Agriculture, Institute of Special Animal and Plant Science, Chinese Academy of Agriculture Sc…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Feline panleukopenia (FPL), caused by the feline panleukopenia virus (FPLV), is a severe and highly contagious viral disease with high morbidity and mortality. Vaccination remains the gold standard for preventing and controlling this debilitating condition. The viral protein VP2 serves as the major immunogen of FPLV and represents the key target antigen in the development of a novel FPLV vaccine. Virus-like particle (VLP)-based vaccines have emerged as next-generation vaccine candidates due to their high immunogenicity and safe profile. In this study, a baculovirus expression vector system (BEVS) was employed to generate FPLV-VLPs through recombinant expression of the VP2 protein of a Chinese epidemic strain (Ala91Ser, Ile101Thr) of FPLV. The resulting FPLV-VLPs demonstrated markedly enhanced antigenicity and hemagglutination activity, achieving a hemagglutination titer of up to 1:216. Following vaccination, immunized cats developed high titers of anti-FPLV hemagglutination inhibition (HI) antibodies (1:216) and exhibited 100% protection against challenge with a virulent epidemic FPLV variant (Ala91Ser, Ile101Thr). These findings demonstrate that FPLV-VLPs hold strong potential as candidates for a novel subunit vaccine against FPLV infection.

Schlagwörter

Stichwörter der Autor:innen

baculovirus expressionfeline panleukopeniafeline panleukopenia virusvaccinevirus-like particles

Autor:innen und Institutionen

  • Key Laboratory of Economic Animal Diseases, Ministry of Agriculture, Institute of Special Animal and Plant Science, Chinese Academy of Agriculture Science, Changchun 130111, China.
  • Changchun Xinuo BioTechnology Co., Ltd., Changchun 130111, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Feng, E., Luo, G., Wang, C., Liu, W., Yan, R., Bai, X., & Cheng, Y. (2025). Generation and Immunogenicity of Virus-like Particles Based on the Capsid Protein of a Chinese Epidemic Strain of Feline Panleukopenia Virus. Veterinary Sciences, 12(5), 503. https://doi.org/10.3390/vetsci12050503

Vancouver

Feng E, Luo G, Wang C, Liu W, Yan R, Bai X, et al. Generation and Immunogenicity of Virus-like Particles Based on the Capsid Protein of a Chinese Epidemic Strain of Feline Panleukopenia Virus. Veterinary Sciences. 2025;12(5):503. doi:10.3390/vetsci12050503

BibTeX
@article{Feng2025,
  author = {Feng, Erkai and Luo, Guoliang and Wang, Chunxia and Liu, Wei and Yan, Ruxun and Bai, Xue and Cheng, Yuening},
  title = {Generation and Immunogenicity of Virus-like Particles Based on the Capsid Protein of a Chinese Epidemic Strain of Feline Panleukopenia Virus},
  journal = {Veterinary Sciences},
  year = {2025},
  volume = {12},
  number = {5},
  pages = {503},
  doi = {10.3390/vetsci12050503}
}
Kostenlos starten →